Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

96.0K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
96.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and preliminary efficacy of autologous bone marrow-derived mesenchymal stem cell transplantation in hereditary cerebellar ataxia: phase I/IIa clinical trial.

Stem cell research & therapy·2026
Same author

Phenotypic Divergence in C19ORF44-Associated Retinal Degeneration despite an Identical Genotype: A Case Report.

Case reports in ophthalmology·2026
Same author

Biallelic Variants in MIMS1 Produce a Form of Spondyloepimetaphyseal Dysplasia With Tracheal Stenosis and Ectodermal Dysplasia (SEMDTSED).

American journal of medical genetics. Part A·2026
Same author

Steroidome Dysregulation and Complement C4 Copy Number Variation in Men With Central Serous Chorioretinopathy.

Investigative ophthalmology & visual science·2026
Same author

Systematic functional evaluation of CNGA1 missense variants associated with retinitis pigmentosa.

Molecular medicine (Cambridge, Mass.)·2026
Same author

The mTOR-Dop1a-Agpat2 axis regulates nuclear phospholipid homeostasis.

iScience·2026

Related Experiment Video

Updated: Nov 20, 2025

Informatic Analysis of Sequence Data from Batch Yeast 2-Hybrid Screens
09:14

Informatic Analysis of Sequence Data from Batch Yeast 2-Hybrid Screens

Published on: June 28, 2018

7.4K

AutoMap is a high performance homozygosity mapping tool using next-generation sequencing data.

Mathieu Quinodoz1,2,3, Virginie G Peter1,2,3,4, Nicola Bedoni5

  • 1Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland.

Nature Communications
|January 23, 2021
PubMed
Summary
This summary is machine-generated.

AutoMap improves homozygosity mapping for rare genetic diseases by analyzing Whole Exome Sequencing and Whole Genome Sequencing data. This new tool enhances mutation identification in recessive conditions, aiding molecular diagnosis and genetic research.

More Related Videos

Targeted DNA Methylation Analysis by Next-generation Sequencing
08:38

Targeted DNA Methylation Analysis by Next-generation Sequencing

Published on: February 24, 2015

37.7K
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.7K

Related Experiment Videos

Last Updated: Nov 20, 2025

Informatic Analysis of Sequence Data from Batch Yeast 2-Hybrid Screens
09:14

Informatic Analysis of Sequence Data from Batch Yeast 2-Hybrid Screens

Published on: June 28, 2018

7.4K
Targeted DNA Methylation Analysis by Next-generation Sequencing
08:38

Targeted DNA Methylation Analysis by Next-generation Sequencing

Published on: February 24, 2015

37.7K
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.7K

Area of Science:

  • Genetics and Genomics
  • Bioinformatics and Computational Biology
  • Medical Genetics

Background:

  • Homozygosity mapping is crucial for identifying mutations in recessive genetic disorders, particularly in consanguineous populations.
  • Traditional homozygosity mapping methods struggle with the large datasets generated by Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS).
  • Existing software often shows suboptimal performance when analyzing WES/WGS variant data.

Purpose of the Study:

  • To develop an advanced computational tool, AutoMap, for efficient homozygosity mapping using Variant Call Format (VCF) data from WES and WGS.
  • To improve the accuracy and performance of variant analysis in medical genetics for identifying disease-causing mutations.
  • To facilitate molecular diagnosis and accelerate genetic research by uncovering novel gene-disease and variant-disease associations.

Main Methods:

  • Developed AutoMap, a web-based and downloadable software tool for homozygosity mapping directly from WES/WGS VCF files.
  • Trained AutoMap using WES data from 26 consanguineous families.
  • Validated the tool's performance against eight existing homozygosity mapping software packages using a matched cohort.

Main Results:

  • AutoMap demonstrated superior overall performance compared to eight other established tools.
  • The tool successfully identified three previously unrecognized gene-disease associations in real cases with negative molecular diagnoses.
  • Multiple novel variant-disease associations were detected, highlighting AutoMap's utility in uncovering genetic links.

Conclusions:

  • AutoMap significantly enhances the capability of homozygosity mapping, especially with modern WES and WGS data.
  • The tool offers substantial benefits for improving molecular diagnostic yield in genetic disorders.
  • AutoMap provides a valuable resource for both clinical geneticists and researchers investigating the genetic basis of diseases.